Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 of remimazolam combined with butorphanol for inhibiting limb movement during painless abortion
ChiCTR2200059793Phase 4Recruiting
- Sponsor
- The Affiliated Shunde Hospital of Jinan University
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam and butorphanol in Induced Abortion (TOP) (2 arms), sponsored by The Affiliated Shunde Hospital of Jinan University. Primary endpoint: dose of remimazolam. Started Apr 2022; status: recruiting.
02
Drugs
remimazolambutorphanol
03
Conditions
Induced Abortion (TOP)
Beyond the preview
Go deeper on ChiCTR2200059793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059793.